Study of HPV 6 L1 virus like paticles as Therapeutic vaccine for genital warts and recurrent respiratory papillomatosis.

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This project will examine the effectiveness of a vaccine designed to prevent tumours and cancers associated with papillomarvirus infection as treatment for existing infections, and will look for predictors of a favourable outcome from treatment.

Funded Activity Details

Start Date: 01-01-2004

End Date: 01-01-2008

Funding Scheme: NHMRC Strategic Awards

Funding Amount: $615,608.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Clinical chemistry (incl. diagnostics)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

AES | Check Inclusion/ exclusion criteria | DTH test | Physical Examination | study material